1
|
Solomon SD, Rizkala AR, Lefkowitz MP, Shi VC, Gong J, Anavekar N, Anker SD, Arango JL, Arenas JL, Atar D, Ben-Gal T, Boytsov SA, Chen CH, Chopra VK, Cleland J, Comin-Colet J, Duengen HD, Echeverría Correa LE, Filippatos G, Flammer AJ, Galinier M, Godoy A, Goncalvesova E, Janssens S, Katova T, Køber L, Lelonek M, Linssen G, Lund LH, O’Meara E, Merkely B, Milicic D, Oh BH, Perrone SV, Ranjith N, Saito Y, Saraiva JF, Shah S, Seferovic PM, Senni M, Sibulo AS, Sim D, Sweitzer NK, Taurio J, Vinereanu D, Vrtovec B, Widimský J, Yilmaz MB, Zhou J, Zweiker R, Anand IS, Ge J, Lam CS, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, Van Veldhuisen DJ, Zannad F, Zile MR, McMurray JJ. Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial. Circ Heart Fail 2018; 11:e004962. [DOI: 10.1161/circheartfailure.118.004962] [Citation(s) in RCA: 88] [Impact Index Per Article: 14.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/29/2018] [Accepted: 06/05/2018] [Indexed: 11/16/2022]
Affiliation(s)
- Scott D. Solomon
- Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (S.D.S., M.A.P.)
| | - Adel R. Rizkala
- Novartis Pharmaceuticals Corporation, East Hanover, NJ (V.C.S., A.R.R., J.J.G., M.P.L.)
| | - Martin P. Lefkowitz
- Novartis Pharmaceuticals Corporation, East Hanover, NJ (V.C.S., A.R.R., J.J.G., M.P.L.)
| | - Victor C. Shi
- Novartis Pharmaceuticals Corporation, East Hanover, NJ (V.C.S., A.R.R., J.J.G., M.P.L.)
| | - JianJian Gong
- Novartis Pharmaceuticals Corporation, East Hanover, NJ (V.C.S., A.R.R., J.J.G., M.P.L.)
| | - Nagesh Anavekar
- Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Australia (N.A.)
| | - Stefan D. Anker
- Division of Cardiology and Metabolism, Department of Cardiology (CVK) and Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) Berlin, Charité Universitätsmedizin Berlin, Germany (S.D.A.)
- Department of Cardiology and Pneumology, University of Göttingen Medical Center, Germany (S.D.A.)
| | | | - Jose L. Arenas
- Centro de Atención e Investigación Cardiovascular del Potosi SC and Hospital Ángeles San Luis, México (J.L. Arenas)
| | - Dan Atar
- Department of Cardiology B, Oslo University Hospital, University of Oslo, Norway (D.A.)
| | - Turia Ben-Gal
- Heart Failure Unit, Cardiology Department, Rabin Medical Center, Petah Tikva, Israel (T.B.-G.)
| | - Sergey A. Boytsov
- National Research Center for Cardiology of the Ministry of Health of the Russian Federation, Moscow, Russia (S.A.B.)
| | - Chen-Huan Chen
- Department of Medicine, National Yang-Ming University, Taipei, Taiwan, Republic of China (C.-H.C.)
| | - Vijay K. Chopra
- Heart Failure Unit, Medanta Medicity, Gurugram, Haryana, India (V.K.C.)
| | - John Cleland
- Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.C.)
- University of Glasgow, United Kingdom. National Heart and Lung Institute, Royal Brompton and Harefield Hospitals, Imperial College, London, United Kingdom (J.C.)
- Community Heart Failure Program, Department of Cardiology, Bellvitge University Hospital and Institut d’Investigació Biomèdica de Bellvitge, University of Barcelona, Spain (J.C.-C.)
| | - Josep Comin-Colet
- Community Heart Failure Program, Department of Cardiology, Bellvitge University Hospital and Institut d’Investigació Biomèdica de Bellvitge, University of Barcelona, Spain (J.C.-C.)
| | - Hans-Dirk Duengen
- National Research Center for Cardiology of the Ministry of Health of the Russian Federation, Moscow, Russia (S.A.B.)
| | | | - Gerasimos Filippatos
- Attikon University Hospital, National and Kapodistrian University of Athens, Greece (G.F.)
- School of Medicine, University of Cyprus, Greece (G.F.)
| | - Andreas J. Flammer
- Department of Cardiology, University Heart Center Zurich, University Hospital Zurich, Switzerland (A.J.F.)
| | - Michel Galinier
- Department of Cardiology, Rangueil University Hospital, Toulouse, France (M.G.)
| | - Armando Godoy
- Universidad Nacional Mayor de San Marcos, Lima, Perú (A.G.)
- Instituto Nacional Cardiovascular INCOR, Lima, Perú (A.G.)
- Scientia Clinical and Epidemiological Research Institute, Trujillo, Perú (A.G.)
| | - Eva Goncalvesova
- Department of Heart Failure/Transplantation, National Cardiovascular Institute, Bratislava, Slovakia (E.G.)
| | - Stefan Janssens
- Department of Cardiology, University Hospitals Leuven, Belgium (S.J.)
| | - Tzvetana Katova
- Clinic of Cardiology, National Cardiology Hospital, Sofia, Bulgaria (T.K.)
| | - Lars Køber
- Department of Cardiology, Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark (L.K.)
| | - Małgorzata Lelonek
- Department of Noninvasive Cardiology, Medical University of Lodz, Poland (M.L.)
| | - Gerard Linssen
- Department of Cardiology, Hospital Group Twente, Almelo and Hengelo, The Netherlands (G.L.)
| | - Lars H. Lund
- Department of Medicine, Karolinska Institutet, and Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden (L.H.L.)
| | - Eileen O’Meara
- Institut de Cardiologie de Montréal, Université de Montréal, Québec, Canada (E.O.M., J.L.R.)
| | - Béla Merkely
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary (B.M.)
| | - Davor Milicic
- Department of Cardiovascular Diseases, University Hospital Center Zagreb, Croatia (D.M.)
| | - Byung-Hee Oh
- Seoul National University Hospital, Seoul National University College of Medicine, Korea (B.-H.O.)
| | | | - Naresh Ranjith
- Department of Cardiology, City Hospital, Durban, South Africa (N.R.)
| | - Yoshihiko Saito
- First Department of Internal Medicine, Nara Medical University, Kashihara, Japan (Y.S.)
| | - Jose F. Saraiva
- Disciplina de Cardiologia Faculdade de Medicina, Pontifícia Universidade Católica de Campinas, Sao Paulo, Brazil (J.F.K.S.)
| | - Sanjiv Shah
- Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL (S.S.)
| | - Petar M. Seferovic
- Department of Cardiology, University of Belgrade School of Medicine, Belgrade University Medical Center, Serbia (P.M.S.)
| | - Michele Senni
- Cardiology Division, Cardiovascular Department, Hospital Papa Giovanni XXIII, Bergamo, Italy (M.S.)
| | - Antonio S. Sibulo
- St Luke’s Heart Institute, St. Luke’s Medical Center, Taguig, Philippines (A.S.S.)
| | - David Sim
- Department of Cardiology, National Heart Centre Singapore (D.S.)
| | - Nancy K. Sweitzer
- Sarver Heart Center, University of Arizona College of Medicine, Tucson (N.K.S.)
| | - Jyrki Taurio
- Department of Cardiology, Tampere University Hospital, Finland (J.T.)
| | - Dragos Vinereanu
- University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital of Bucharest, Romania (D.V.)
| | - Bojan Vrtovec
- University Medical Centre, Ljubljana, Slovenia (B.V.)
| | - Jiří Widimský
- First Faculty of Medicine, Charles University Prague, Czech Republic (J.W.)
| | - Mehmet B. Yilmaz
- Department of Cardiology, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey (M.B.Y.)
| | - Jingmin Zhou
- Department of Cardiology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China (J.Z.)
| | - Robert Zweiker
- Department of Cardiology, Medical University Graz, Austria (R.Z.)
| | - Inder S. Anand
- Department of Medicine, VA Medical Center and University of Minnesota, Minneapolis (I.S.A.)
| | - Junbo Ge
- Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.)
| | - Carolyn S.P. Lam
- National Heart Centre Singapore and Duke-National University of Singapore (C.S.P.L.)
| | - Aldo P. Maggioni
- Associazione Nazionale Medici Cardiologi Ospedalieri, Florence, Italy (A.P.M.)
| | | | - Milton Packer
- Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX (M.P.)
| | - Marc A. Pfeffer
- Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (S.D.S., M.A.P.)
| | - Burkert Pieske
- Department of Internal Medicine, Cardiology Charité, Universitaetsmedizin Berlin, Campus Virchow Klinikum Berlin, Germany (B.P., H.-D.D.)
| | | | - Jean L. Rouleau
- Institut de Cardiologie de Montréal, Université de Montréal, Québec, Canada (E.O.M., J.L.R.)
| | - Dirk J. Van Veldhuisen
- University Medical Center Groningen, University of Groningen, The Netherlands (D.J.V.V.)
| | - Faiez Zannad
- Inserm CIC 1433 and Université de Lorraine, Centre Hospitalier Ré gional Universitaire, Nancy, France (F.Z.)
| | - Michael R. Zile
- Medical University of South Carolina and Ralph H. Johnson Veterans Administration Medical Center, Charleston (M.R.Z.)
| | | |
Collapse
|
14
|
Anavekar N, Bais R, Carney S, Davidson J, Eris J, Gallagher M, Johnson D, Jones G, Sikaris K, Lonergan M, Ludlow M, Mackie J, Mathew T, May S, McBride G, Meerkin M, Peake M, Power D, Snelling P, Voss D, Walker R. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement. Clin Biochem Rev 2005; 26:81-6. [PMID: 16450015 PMCID: PMC1240034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/06/2023]
Abstract
The systematic staging of chronic kidney disease (CKD) by glomerular filtration measurement and proteinuria has allowed the development of rational and appropriate management plans. One of the barriers to early detection of CKD is the lack of a precise, reliable and consistent measure of kidney function. The most common measure of kidney function is currently serum creatinine concentration. It varies with age, sex, muscle mass and diet, and interlaboratory variation between measurements is as high as 20%. The reference interval for serum creatinine concentration includes up to 25% of people (particularly thin, elderly women) who have an estimated glomerular filtration rate (eGFR) that is significantly reduced (< 60 mL/min/1.73 m). The recent publication of a validated formula (MDRD) to estimate GFR from age, sex, race and serum creatinine concentration, without any requirement for measures of body mass, allows pathology laboratories to "automatically" generate eGFR from data already acquired. Automatic laboratory reporting of eGFR calculated from serum creatinine measurements would help to identify asymptomatic kidney dysfunction at an earlier stage. eGFR correlates well with complications of CKD and an increased risk of adverse outcomes such as cardiovascular morbidity and mortality. We recommend that pathology laboratories automatically report eGFR each time a serum creatinine test is ordered in adults. As the accuracy of eGFR is suboptimal in patients with normal or near-normal renal function, we recommend that calculated eGFRs above 60 mL/min/1.73 m be reported by laboratories as "> 60 mL/min/1.73 m", rather than as a precise figure.
Collapse
|